1Takai N,Miyazaki T,Nishida M,et al.Clinical relevance of Elf-1 over expression in endometrial arcinoma[J].Gynecoloncol,2003,89(3):408-413
2Salvesen HB,Stefanssoni,Kalvenes MB,et al.Loss of PTEN expression is associated withmetastatic disease in patients with endimetrial carcinoma[J].Cancer,2002,94(8):2185
3Minaguchi T,Yoshikawa H,Oda K,et al.PTEN mutation located only outside exonsS,6and7 is anindependent predictor of favorable survival in endometrial carcinomas[J].Clincancerres,2001,7(9):2636
4Kanamori Y,Kigawa J,Itamochi H,et al.PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative che motherapy[J].Intjcancer,2002,100(6):686
5Terakawa N,Kanamori Y.Loss of PTEN expression followed by akt phosphorylat is a poorprognostic factor for patients with en dometrial cancer[J].Endocrrelatcancer,2003,10 (2):203
6Yabushita H,Noguchi M,Kinoshita S,et al.Angiostatin express in endometrial cancer[J].Oncolrep,2002,9(6):1193
7Sivridise,Giatromanolaki A,Anastasiadisp,et al.Angiogeniccooperation VEGF and stromal cell TP in endometrial carcino mas[J].J Pathol,2002,196(4):416
8Yokyoma Y,Chrnock Jones Ds,Licence D.Expression of vascular endometrial growth factor VEGF-D and its recepter,vegfr ecepter3,as aprognostic factor in endotrial carcinoma[J].Clincancer,2003,9(4):1361
9Takai N.Survivin expression correlateswith clinical stage,histological grade,invasive behavior and survival rate in endometrial carcinoma[J].Cancerlett,2002,184 (1):105
10Rainer L,Takayuki E.Correlation of survivin mrna detection with histologic diagnosis in nomal endometrium and endometrial carcinoma[J].Actaobsetgynecolscand,2002,81:162
